s6y
Company name or ticker
Search
Apimeds Pharmaceuticals US, Inc.
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Thursday, April 9, 2026
Accession number
0001213900-26-042030
Documents
AMENDMENT NO. 1 TO FORM 8-K
425
On sec.gov
Filing index
All files
Complete submission text
SGML header